Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ardelyx

4.13
-1.3400-24.50%
Post-market: 4.170.0400+0.97%19:59 EDT
Volume:20.52M
Turnover:87.73M
Market Cap:984.41M
PE:-24.82
High:4.57
Open:4.05
Low:4.02
Close:5.47
Loading ...

Ardelyx Inc: Tenapanor Approved in China for Hyperphosphatemia

THOMSON REUTERS
·
26 Feb

Tenapanor Approved in China for Hyperphosphatemia

GlobeNewswire
·
26 Feb

Ardelyx to Participate in Upcoming Investor Conferences

GlobeNewswire
·
26 Feb

Institutional investors may adopt severe steps after Ardelyx, Inc.'s (NASDAQ:ARDX) latest 11% drop adds to a year losses

Simply Wall St.
·
26 Feb

Stock Track | Ardelyx Stock Plummets 5.16% as Trade Secret Risks Loom

Stock Track
·
21 Feb

Ardelyx Price Target Maintained With a $5.50/Share by HC Wainwright & Co.

Dow Jones
·
21 Feb

Ardelyx Inc (ARDX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Challenges

GuruFocus.com
·
21 Feb

Ardelyx Inc. Grapples with Trade Secret Risks Threatening Financial Stability

TIPRANKS
·
21 Feb

Q4 2024 Ardelyx Inc Earnings Call

Thomson Reuters StreetEvents
·
21 Feb

Ardelyx Reports Strong 2024 Financial Performance

TIPRANKS
·
21 Feb

Stock Track | Ardelyx (ARDX) Plummets 14.07% as Quarterly Results Disappoint

Stock Track
·
20 Feb

Stock Track | Ardelyx Shares Soar 6.92% Pre-market on Impressive Q4 Earnings Beat

Stock Track
·
20 Feb

Ardelyx Q4 2024 GAAP EPS $0.02 Beats $0.01 Estimate, Sales $116.13M Beat $109.94M Estimate

Benzinga
·
20 Feb

Ardelyx Inc - Reports 2024 Total Revenue of $333.6 Million

THOMSON REUTERS
·
20 Feb

Ardelyx Q4 Product Sales USD 111.003 Million

THOMSON REUTERS
·
20 Feb

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
20 Feb

BioCryst Pharmaceuticals (BCRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks
·
17 Feb

Ardelyx (ARDX) Earnings Expected to Grow: Should You Buy?

Zacks
·
13 Feb

Ardelyx price target raised to $8 from $7 at Piper Sandler

TIPRANKS
·
27 Jan

Chairman David Mott Bets $1M on Ardelyx--Is This Biotech Stock Set to Skyrocket?

GuruFocus.com
·
24 Jan